HealthRx and Henry Meds are both cash-pay telehealth options, but they package their weight-management programs differently. The most useful comparison is the exact medication format and total plan price you would actually be offered.
Price positioning
HealthRx currently advertises compounded semaglutide from $99/month and compounded tirzepatide from $179/month on 12-month prepaid plans. Henry Meds says GLP-1 weight-management pricing starts at $179/month and can include provider visits, medication, supplies and ongoing support.
Program breadth
Henry Meds markets several weight-management medication formats. HealthRx is more tightly centered on injectable compounded semaglutide and tirzepatide in its main GLP-1 offer.
Commitment and total cost
Do not compare only the lowest monthly number. Check whether payment is monthly or prepaid, what medication and dose the price applies to, how refills work, and whether changing treatment changes your cost.
Regulatory distinction
Where compounded medications are involved, neither platform should be evaluated as though it were selling an FDA-approved generic equivalent. FDA says compounded drugs are not FDA-approved and are not verified by FDA before marketing for safety, effectiveness or quality.
Bottom line
HealthRx has a strong simple-price story; Henry Meds has broader program variety. The better fit depends on the actual treatment a clinician recommends and the payment structure you prefer.
Sources & verification
We use primary sources for time-sensitive commercial and regulatory claims.
- HealthRx — Pricing
- Henry Meds — GLP-1 weight-management program
- FDA — Concerns with unapproved GLP-1 drugs used for weight loss
Last reviewed: August 19, 2026